|COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring.|
IMAGINATOR: A proof of concept trial of an intervention for young people who self harm
If you have a question about this talk, please contact Rachel Elliott.
Cambridge Clinical Research centre in Affective disorders presents:
Dr Martina Di Simplicio will present a talk on the proof-of-concept trial “Imaginator” investigating a brief psychological therapy for self-harm in young people. Self-harm is a common transdiagnostic behavior in adolescents and young people, and repetitive self-harm is a risk factor for future psychopathology.
Admissions following self-harm in Cambridgeshire in a 2015 county survey were reported as higher than the national average in the U.K. To date, effective easily accessible and age-specific interventions targeting self-harm are missing. The Imaginator trial delivers two face to face sessions of an intervention combining techniques from motivational interviewing and imagery-focused cognitive therapy, followed by support via a smartphone app.
The talk will run from 12.30 to 1.30pm at the Herchel Smith Building for Brain and Mind Sciences on the Forvie site at Addenbrooke’s Hospital in Cambridge (Location: http://c2ad.mrc-cbu.cam.ac.uk/location/ )
These seminars are open to anyone who wishes to attend. This includes mental health professionals, researchers, students, service-users and carers.
This talk is part of the C2AD seminar Series series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
Other listsCambridge Area Worm Meeting Meeting the Challenge of Healthy Ageing in the 21st Century SciBar
Other talks“Targetting Tribbles 2 pseudokinase with drugs” Innovative statistical approaches for studies in anti-infective drug combination development Dr Marcus Wachtmeister (BMW Group): 'Electrification and Data: Challenges to the Automotive Sector' Asclepiadaceae Visualising phenotypic and genomic relationships with DECIPHER - A community endeavour to map the Clinical Genome